J R Leclerc

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group
    J R Leclerc
    The Montreal General Hospital, McGill University, Quebec
    Arch Intern Med 158:873-8. 1998

Collaborators

Detail Information

Publications1

  1. ncbi The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group
    J R Leclerc
    The Montreal General Hospital, McGill University, Quebec
    Arch Intern Med 158:873-8. 1998
    ..Most of these thrombi are asymptomatic and of unknown clinical significance. Nevertheless, because they have the potential to grow, limiting prophylaxis to the in-hospital period may provide inadequate protection...